What once seemed an impossible battle for three-year-old Delshad Alukure has today become one of the most compelling testimonies of hope emerging from the Ghana Medical Trust Fund (GMTF).
Born with two life-threatening heart conditions — Double Outlet Right Ventricle (DORV) and Patent Ductus Arteriosus (PDA) — Delshad’s future hung precariously in the balance from the very beginning. The diagnosis was clear. The medical expertise existed. The life-saving surgery was available. Yet, like thousands of Ghanaian families confronted by chronic illnesses, one obstacle stood firmly between the young boy and survival: the staggering cost of treatment.
The surgery required to save Delshad’s life was estimated at more than GH¢150,000 — an amount far beyond the reach of his family.
For his parents, the diagnosis was devastating. Faced with the prospect of losing their son, they watched helplessly as financial limitations threatened to deny him the chance to live, grow, and pursue his dreams.
Then came a lifeline.
Through the Ghana Medical Trust Fund’s pilot intervention programme, Delshad received the financial support needed to undergo the complex surgery that would ultimately save his life.
Today, less than two months after the procedure, the energetic three-year-old is healthy, active, and embracing a future that once appeared unattainable.
His remarkable recovery has become a powerful symbol of the impact the Ghana Medical Trust Fund is making across the country.
Speaking at the ongoing Ghana-UK Investment Summit in London, Administrator of the Ghana Medical Trust Fund, Adjoa Obuobia Darko-Opoku, described Delshad’s story as a clear demonstration of how strategic healthcare interventions can transform lives and restore hope to families facing overwhelming medical challenges.
According to her, behind every patient supported by the Trust Fund is a family protected from financial catastrophe, a life saved, and a community strengthened.
“Delshad is not alone,” she noted.
Across Ghana, thousands of families continue to grapple with chronic non-communicable diseases, including cancer, kidney disease, cardiovascular conditions, diabetes, and stroke. For many households, the financial burden of treatment can be as devastating as the illness itself, often forcing families to deplete savings, sell property, and sacrifice lifelong investments in desperate attempts to save loved ones.
Recognizing this growing national challenge, the Ghana Medical Trust Fund was established with a clear mission: ensuring that access to specialized healthcare is determined by medical need rather than financial capacity.
Since its establishment, the Fund has pursued an ambitious agenda built around four strategic pillars — patient support, healthcare infrastructure development, specialist workforce training, and medical research.
One of its earliest initiatives involved a nationwide assessment of Ghana’s healthcare system. The exercise revealed significant gaps in specialist care, diagnostic services, medical equipment, and treatment infrastructure.
The findings prompted swift action.
Since then, the Trust Fund has facilitated the distribution of critical medical equipment, including dialysis machines, intensive care unit beds, and patient monitors to healthcare facilities across the country.
In addition, the Fund is spearheading the establishment of three state-of-the-art cardiology centres at Korle Bu Teaching Hospital, Komfo Anokye Teaching Hospital, and Tamale Teaching Hospital, a move expected to significantly strengthen Ghana’s capacity to diagnose and treat cardiovascular diseases.
Beyond infrastructure investments, the Fund is also supporting the training of specialist healthcare professionals through partnerships with key medical institutions. The objective is to ensure that every region of Ghana has access to adequately trained specialists capable of managing chronic diseases closer to patients’ homes.
Already, the results are becoming evident.
As part of its pilot phase, the Ghana Medical Trust Fund supported 50 patients from across the country, providing financial assistance for life-saving interventions, including heart surgeries, brain surgeries, chemotherapy, radiotherapy, and other specialized treatments.
For many beneficiaries, the support represented the difference between life and death.
For families like Delshad’s, it represented the difference between despair and hope.
Yet, the leadership of the Trust Fund believes this is only the beginning.
The long-term vision includes expanding specialist healthcare services nationwide, increasing access to advanced diagnostic technologies, strengthening cancer treatment centres, and ensuring that no Ghanaian is denied essential healthcare because of financial constraints.
To achieve this vision, the Fund is calling on development partners, investors, philanthropists, corporate organizations, and the Ghanaian diaspora to support the initiative.
Healthcare, the Fund argues, is not merely a medical concern. It is an economic, social, and national development imperative.
And as Delshad’s extraordinary recovery continues to inspire hope, it offers a glimpse into what is possible when financial barriers to healthcare are removed.
The Ghana Medical Trust Fund is proving that lives can be saved, futures can be reclaimed, and families confronting their darkest moments do not have to walk alone.
For Delshad and the many others whose lives have already been transformed, the Fund is doing far more than paying medical bills.
It is giving people a second chance at life.
